Baseline characteristics of patients with frequent exacerbations in the POET-COPDÔ trial

L. M. Fabbri, C. Vogelmeier, M. P. M. H. Rutten-van Mölken, K. F. Rabe, T. Glaab, F. Rühmkorf, H. Schmidt, K. M. Beeh (Modena, Italy; Marburg, Grosshansdorf, Ingelheim, Wiesbaden, Germany; Rotterdam, Netherlands)

Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation
Session: Diagnosis and predictors of COPD exacerbation
Session type: Oral Presentation
Number: 405
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. M. Fabbri, C. Vogelmeier, M. P. M. H. Rutten-van Mölken, K. F. Rabe, T. Glaab, F. Rühmkorf, H. Schmidt, K. M. Beeh (Modena, Italy; Marburg, Grosshansdorf, Ingelheim, Wiesbaden, Germany; Rotterdam, Netherlands). Baseline characteristics of patients with frequent exacerbations in the POET-COPDÔ trial. Eur Respir J 2011; 38: Suppl. 55, 405

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Baseline characteristics of patients admitted for the first time for COPD exacerbation. The ²phenotype and course of COPD² (PAC-COPD) study
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007


Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials
Source: Eur Respir J 2006; 28: Suppl. 50, 175s
Year: 2006

The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017


Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008


A clinical and outcomes assessment of the management of acute episodes of chronic bronchitis (AECB) : the MOSAIC study - baseline characteristics of screened patients
Source: Eur Respir J 2002; 20: Suppl. 38, 544s
Year: 2002

Effect of treatment on morning symptoms in COPD. Correlation between doctors and patients in the evaluation of symptoms. SINCON Study
Source: International Congress 2018 – Patient-reported outcomes and scores in COPD
Year: 2018

Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study
Source: Annual Congress 2011 - COPD management
Year: 2011

LATE-BREAKING ABSTRACT: Baseline demographic and clinical profile of patients with and without cardiovascular diseases in the assessment of comorbidities in COPD in european symptomatic subjects from primary care (ACCESS) study
Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura
Year: 2013


Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
Source: International Congress 2018 – COPD management
Year: 2018


Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013

Clinical characteristics and outcomes in hospitalized COVID-19 patients with COPD
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019

Baseline characteristics of the first 5,000 COPD patients enrolled in the TORCH survival study
Source: Eur Respir J 2003; 22: Suppl. 45, 578s
Year: 2003

COPD patients with radiological pneumonia have worse mortality outcome compared to non-pneumonic COPD exacerbations: UK multi-centre study
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010



Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010


Relationship between baseline rescue medication use and reductions in COPD exacerbation rates: a subgroup analysis of the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021


Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013